MichelleBradburyMD, PhD
Radiology • New York, NYNeuroradiology, Nuclear Medicine
Professor, Radiology and Endowed Professor of Imaging Research, Weill Cornell Medicine; Director, Molecular Imaging Institute and Director, Perioperative Imaging & Engineered Technologies for Oncology. Head, Cross-Campus Research Collaborations and Innovations, Cornell Institute for Engineering Innovations in Medicine, Sandra and Edward Meyer Cancer Center
Dr. Bradbury is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
New York, NY 10065Phone+1 212-746-4055
Summary
- I am the Director of the Molecular Imaging Institute, Perioperative Imaging & Engineered Technologies, and Cross-Campus Research Collaborations/Innovations, Sandra and Edward Meyer Cancer Center. As a clinician-scientist with 20 years experience in molecular imaging and applied nanomaterials, I co-develop ultrasmall silica nanoparticles for preclinical/clinical diagnostic and therapeutic applications.
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Neuroradiology, 2002 - 2003- Wake Forest University Baptist Medical CenterResidency, Radiology-Diagnostic, 1998 - 2002
- Wake Forest University Baptist Medical CenterInternship, Surgery, 1997 - 1998
George Washington University School of Medicine and Health SciencesClass of 1997
Certifications & Licensure
NY State Medical License 2003 - 2026
NJ State Medical License 2006 - 2023
NC State Medical License 1998 - 2003- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Neuroradiology
Awards, Honors, & Recognition
- Co-Chair, Innovations & Technology Team Memorial Sloan Kettering Cancer Center, 2015-2016
- Director, Intraoperative Imaging Memorial Sloan Kettering Cancer Center, 2014-2016
Clinical Trials
- Image-Guided Stereotactic Biopsy of High Grade Gliomas Start of enrollment: 2009 Sep 16
- PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study Start of enrollment: 2011 Jan 01
- Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases Start of enrollment: 2014 Apr 03
Publications & Presentations
PubMed
- 2 citationsA translational framework to DELIVER nanomedicines to the clinic.Paul Joyce, Christine J Allen, María José Alonso, Marianne Ashford, Michelle S Bradbury
Nature Nanotechnology. 2024-11-01 - 5 citationsEngineered Ultrasmall Nanoparticle Drug-Immune Conjugates with "Hit and Run" Tumor Delivery to Eradicate Gastric Cancer.Li Zhang, Virginia Aragon-Sanabria, Anusha Aditya, Marcello Marelli, Tianye Cao
Advanced Therapeutics. 2023-03-01 - 8 citationsUltrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of Cancer.Fei Wu, Pei-Ming Chen, Thomas C Gardinier, Melik Z Turker, Aranapakam M Venkatesan
ACS Nano. 2022-12-27
Press Mentions
Memorial Sloan Kettering Awards & AppointmentsDecember 16th, 2020
Multiplexed C Dots Track Cancer Cells to Improve Patient CareDecember 6th, 2019
Cornell Dots Equipped with Antibody Fragments Offer a New Cancer WeaponOctober 12th, 2018- Join now to see all
Grant Support
- MSKCC-Cornell Center for Translation of Cancer NanomedicinesNational Cancer Institute2015–2020
- Ultrasmall Nanoparticles for Evaluating Cell Death ProgramsNew York State2015–2017
- Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Radiotherapeutic Platforms for NanomedicineNational Cancer Institute2012–2017
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
